ada glp-1 '26: Lilly's dominance, Pfizer's 'foundational' drug and Roche's 'me-too' option New evidence on GLP-1 receptor

Pay attention to these warning signs: Dizziness or lightheadedness during or after exercise this often signals dehydration or insufficient caloric intake Extreme fatigue that persists for hours after a workout, rather than the normal post-exercise tiredness Nausea that worsens with physical activity especially common during dose increases Heart rate that feels unusually elevated for the level of effort you are putting in Muscle weakness or inability to recover between sessions this may indicate inadequate protein intake A 15-minute walk on a tough day is always better than skipping movement entirely

Xu H, et al

#obesity #glp1 #healthcareinnovation #healthcaredata Jonathan Rossmans Post Fun fact from a data deep dive that I helped work on: Medicaid spending on GLP-1s has grown exponentially over the past five years with 36 states now covering at least one of the FDA-approved GLP-1s for obesity (Wegovy, Zepbound, or Saxenda) Why

Still, a medication used by roughly one in nine American adults can influence more than healthcare spending

" " I walked into my appointment today I wasnt sure what to expect but to my surprise it was a beautiful establishment inside and very warm and welcoming